Geoffrey D.Oliver (Geoff)

Of Counsel

Washington + 1.202.879.5447

Connect:

Share

Geoff Oliver's practice focuses on antitrust matters, with an emphasis on government merger and conduct investigations and matters involving antitrust and patent law. He represents high-tech and manufacturing companies in the computer, semiconductor, consumer electronics, pharmaceutical, health care, and medical devices industries. He has litigated merger, conduct, and IP-related matters in federal court and in administrative proceedings before the Federal Trade Commission and the International Trade Commission. He regularly counsels companies with respect to joint ventures, licensing and distribution agreements, and other commercial arrangements. Geoff co-coordinates the Firm's practice involving application of antitrust law to issues involving intellectual property.

Before joining Jones Day in 2007, Geoff held various positions in the Federal Trade Commission's Bureau of Competition, including Assistant Director responsible for the Anticompetitive Practices Division. At the FTC, he supervised numerous nonpublic investigations, litigated merger and non-merger cases, and participated in various policy initiatives involving standard-setting, intellectual property, joint ventures, and other issues. Earlier in his career, Geoff practiced in Brussels, Belgium as well as Washington, D.C.

Geoff has written on antitrust enforcement topics and has spoken on antitrust and intellectual property issues in the United States and abroad. He was the lead editor of the ABA Antitrust Section's treatise, Antitrust Issues in International Intellectual Property Licensing Transactions, and formerly served as the chair of the Antitrust Committee of the American Intellectual Property Law Association and on the board of editors of the ABA's Antitrust magazine.

Experience

  • Reynolds American acquired by British American Tobacco Plc in deal valued at $49 billionJones Day advised Reynolds American Inc. ("RAI") regarding the acquisition by British American Tobacco, p.l.c. ("BAT") of 57.8 percent of the outstanding shares of RAI not owned by BAT and its affiliates in a transaction valued at $49 billion.
  • Cardinal Health acquires rights to Lymphoseek® from Navidea BiopharmaceuticalsJones Day advised Cardinal Health in its acquisition of Navidea Biopharmaceuticals' rights to Lymphoseek® in North America for lymphatic mapping, lymph node biopsy, and the diagnosis of metastatic spread to lymph nodes for the staging of cancer.
  • Wabtec acquires Faiveley Transport for $1.8 billionJones Day advised Wabtec Corporation in the acquisition of Faiveley Transport S.A., a global supplier of high added value integrated systems for the railway industry, for a total of $1.8 billion in cash and stock, including assumed debt.
  • PinnacleHealth System and Penn State Hershey attempt to merge Pennsylvania hospitalsJones Day represented PinnacleHealth System and Penn State Milton S. Hershey Medical Center as antitrust counsel in the hospitals' proposed merger.
  • ACI Worldwide sells its community financial services business to Fiserv for $200 millionJones Day advised ACI Worldwide, Inc. in the sale of its community financial services business, including its Self-Service Banking, WebFederal On-Line Banking, Advantage, Advantage Bill Pay, and Architect Banking product lines, to Fiserv, Inc. for $200 million.
  • Bunge and Solazyme expand joint venture to make oils from renewable sources using microbesJones Day assisted Bunge Global Innovation, LLC in renegotiating its joint venture agreements with Solazyme, Inc. in the Netherlands and Brazil to, among other things, expand the products to be made and the geographies and manner in which all such products will be sold.
  • Reynolds American acquires Lorillard for $27.4 billionJones Day advised Reynolds American Inc. (NYSE: RAI) in its acquisition of Lorillard, Inc. for $27.4 billion and in the related $7.1 billion divestiture to an affiliate of Imperial Tobacco Group and $4.7 billion investment by British American Tobacco, RAI's largest shareholder.
  • Procter & Gamble settles patent infringement and antitrust claims related to teeth whitening stripsJones Day represented Procter & Gamble in patent infringement litigation against CAO Group for infringement of certain patents relating to teeth whitening strips.
  • Hertz wins antitrust approval for long-fought acquisition of Dollar ThriftyJones Day secured antitrust approval from the U.S. Federal Trade Commission (FTC) for the $2.3 billion acquisition by U.S. car rental company Hertz Global Holdings, Inc. of Dollar Thrifty Automotive Group.
  • Yale-New Haven Hospital obtains antitrust approval for proposed Saint Raphael's acquisitionJones Day represented Yale-New Haven Hospital ("YNHH") in connection with all antitrust matters related to its acquisition of a competing hospital, the Hospital of Saint Raphael's in New Haven, Connecticut.
  • SmartDrive's request for three inter partes reexaminations and one ex parte reexamination granted by USPTO in connection with patents directed to vehicle event recording devicesIn connection with its representation of defendant SmartDrive Systems, Inc. in defending patent infringement and trade secret misappropriation claims relating to in-vehicle video event recorder technologies, Jones Day filed three inter partes reexamination requests under newly enacted standards under the Leahy-Smith America Invents Act, all of which were subsequently granted by the USPTO. 
  • Texas Instruments makes $6.5 billion acquisition of analog device and subsystems specialist National SemiconductorJones Day advised Texas Instruments Incorporated, a global analog and digital semiconductor IC design and manufacturing company, in connection with its $6.5 billion acquisition and related financing of National Semiconductor Corporation, a semiconductor manufacturer that specializes in analog devices and subsystems.
  • Reynolds American sells Lane, Limited to Scandinavian Tobacco Group A/S (STG) for $205 millionJones Day advised Reynolds American Inc. in its $205 million sale of Lane, Limited to Scandinavian Tobacco Group A/S (STG), a global company based in Denmark.
  • International medical device manufacturer is third party in patent and antitrust dispute involving pulse oximetry productsJones Day is representing an international medical device manufacturer as a third party in a patent and antitrust dispute concerning its pulse oximetry products.
  • U-Haul successfully resolves FTC antitrust investigationOn behalf of truck rental company U-Haul International, Inc., Jones Day successfully resolved a Federal Trade Commission investigation into an alleged invitation to collude in violation of Section 5 of the FTC Act.
  • InnoLux obtains antitrust clearance for three-way merger with Chi Mei and TPOJones Day represented InnoLux Display Corp. in obtaining clearance under the antitrust and competition laws in the United States and the European Union for its three-way merger with Chi Mei Optoelectronics Corp. and TPO Displays Corp.
  • SanDisk asserts patent over flash memory systems before the ITCJones Day represented SanDisk Corporation as a complainant in an ITC action regarding flash memory systems.
  • RFID Consortium obtains favorable business review letter for patent pool from Department of JusticeJones Day represented the RFID Consortium LLC in its request for a business review letter from the Department of Justice Antitrust Division with respect to its proposed licensing of a pool of patents essential to the manufacture of products in compliance with certain ultra-high frequency radio frequency identification standards.
  • St. Elizabeth Medical Center cleared by FTC to merge with St. Luke Hospitals in Northern KentuckyJones Day successfully persuaded the Federal Trade Commission (FTC) not to seek a preliminary injunction against a hospital merger proposed by St. Elizabeth Medical Center.
  • CIGNA obtains antitrust clearance to acquire Great-West HealthcareJones Day represented CIGNA Corporation as antitrust counsel in its $1.5 billion acquisition of Great-West Healthcare, a subsidiary of Great-West Life & Annuity, Inc.
    • View All

    October 2019 Commentaries

    Seventh Circuit Curtails FTC's Authority to Seek Restitution

    March 2019 Commentaries

    Third Circuit Limits FTC’s Ability to Seek Monetary Remedies for Past Conduct

    June 2017 Jones Day Publications

    Leegin's 10-Year Checkup: US Influence On RPM Overseas, Law 360

    January 2017 Alerts

    Antitrust Alert: U.S. Agencies Issue New Antitrust Guidelines for Intellectual Property Licensing

    January 2017 Alerts

    Antitrust Alert: U.S. DOJ and FTC Publish Updated Antitrust Guidelines for International Enforcement with Goal to Maintain Agency Flexibility

    November 2016 Commentaries

    Agencies' Proposed International Antitrust Guidelines Hint at Aggressive Enforcement

    October 2016 Commentaries

    Federal Trade Commission Releases Long-Awaited Report on Patent Assertion Entities

    September 2016 Alerts

    Antitrust Alert: U.S. Agencies Propose New Antitrust Guidelines for Intellectual Property Licensing

    August 2016 Alerts

    Antitrust Alert: U.S. FTC Challenges Ambiguous "Invitation to Collude" in Supplier-Distributor Relationship

    May 2016 Alerts

    Antitrust Alert: Medical Material Manufacturer Settles FTC Charges of Using Exclusive Contracts to Impede Competition
    View All

    Additional Publications

    • Spring 2010
      Of Tenors, Real Estate Brokers and Golf Clubs: A Quick Look at Truncated Rule of Reason Analysis, Antitrust Magazine, Volume 24, No. 2
    • October 2008
      Antitrust Alert: Department of Justice Issues First Patent-Pool Business Review Letter Since Issuing 2007 Antitrust & IP Report

    Speaking Engagements

    • October 24, 2013
      The FTC's Enforcement Priorities and Reverse-Payment Settlements in Pharma Cases, moderator, Antitrust/ADR/Chemical Substances/Food & Drug Committees, AIPLA Annual Meeting
    • July 25, 2013
      Standard-Essential Patents and Injunctive Relief, New York City Bar Association Antitrust & Trade Regulation Committee
    • August 2, 2012
      Emerging Trends in International Intellectual Property Law
    • March 30, 2011
      Signaling and Invitations to Collude: How to Draw the Lines, ABA Antitrust Section Spring Meeting
    • January 26, 2011
      Antitrust and IP Licensing, Jones Day MCLE University (Presentation slides)
    • December 10, 2010
      Antitrust Issues in Trade Associations, Presentation to Visiting Delegation of the State Administration for Industry & Commerce (SAIC), P.R.C.
    • September 21, 2010
      Truncated Rule of Reason Analysis in Antitrust Representations, Strafford Webinar
    • March 25, 2009
      Global Competition Review Section 2 Roundtable
    • December 2, 2008
      Antitrust & IP Issues in the New Administration, Internationalen Handelskammer Frankfurt
    • October 22, 2008
      June 25, 2008
      Update on Recent Developments Affecting Standards Organizations, ANSI Legal Issues Forum
    • October 2, 2008
      Recent Developments Involving Patent Pools, Law Seminars International
    • October 2008
      Discussion on the application of Section 5 to standard-setting issues, panelist, Section 5 of the FTC Act as a Competition Statute Workshop
    • May 21, 2008
      The Implications of the Rambus Decision, American Bar Association Section of Antitrust Law
    • 16 avril 2008
      Petit-déjeuner Concurrence, Séminaire Jones Day Paris
    • April 16, 2008
      Recent Trends in U.S. Antitrust Merger Litigation and the Antitrust-Intellectual Property Interface
    • April 10, 2008
      Antitrust Issues in Standard-Setting, ICSCA/American National Standards Institute Conference
    • January 18, 2008
      Antitrust Issues in Standard-Setting, Jones Day University
    • November 29, 2007
      An Introduction To Significant Issues In U.S. Law: A Presentation for a Delegation of Lawyers and Officials from Jiangsu Province, China
    • November 5, 2007
      Litigation Strategies for Standards, Managing Your IP In the Digital Age, Intellectual Property Owners Association
    • October 11, 2007
      Dealing with Government Agencies, Standards Bodies & Patent Pools, Law Seminars International
    • April 12, 2007
      In the Matter of Rambus, Inc., 15th Annual Conference on Intellectual Property Law and Policy, Fordham University School of Law
    • March 22, 2007
      FTC v. Rambus 2007: Analysis of the Commission's Liability and Remedy Decisions, Practicing Law Institute
    • August 30, 2006
      The FTC's Rambus Decision: Antitrust Lessons Learned, Practicing Law Institute
    • October 18, 2005
      Antitrust Issues in Standard-Setting, Law Seminars International
    • October 6, 2005
      June 15, 2005
      Antitrust Issues in Standard-Setting, American National Standards Institute
    • April 21, 2005
      Antitrust Issues in Standard-Setting, ICSCA XII Conference, Industry Cooperation on Standards & Conformity Assessment
    • January 27, 2005
      Antitrust Issues in Standard-Setting, New York Bar Association
    • April 26, 2002
      The Three Tenors: In the Matter of Polygram et al., Section 1 Committee Program, ABA Antitrust Section Spring Meeting
    • June 25-27, 2001
      Conducting Effective Government Investigations, Mexican Federal Competition Commission
    • March 14-16, 2000
      Recent Enforcement of Section 2 in the United States, Training Program, Asia-Pacific Economic Cooperation/Partners for Progress
    • September 29, 1999
      Merger Enforcement in High-Tech Industries, High Tech Mergers & Acquisitions, Glasser LegalWorks Seminars
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.